Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V6IM
|
|||
Former ID |
DNCL002575
|
|||
Drug Name |
SBG
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 3 | [1] | |
Company |
Biotec Pharmacon
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00632008) Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.